If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARIX.L Regulatory News (ARIX)

  • There is currently no data for ARIX

PDMR Notification & Director Shareholding

2 Nov 2023 18:20

Arix Bioscience PLC (ARIX) PDMR Notification & Director Shareholding 02-Nov-2023 / 18:20 GMT/BST


Arix Bioscience plc("Company")

PDMR Notification & Director Shareholding

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified that Peregrine Moncreiffe, Director and Chairman of the Company purchased 60,000 Ordinary shares of 0.001 pence each in the Company (β€œShares”) on 2nd November 2023 at a price of Β£1.1469 per share.

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Peregrine Moncreiffe

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Β Non-Executive Director and Chair of the Board

b)

Β 

Initial notification /Amendment

Β 

Initial Notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Β 

Name

Β 

Arix Bioscience plc

b)

Β 

LEI

Β 

213800OVT3AHQCXNIX43

Β 

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Β 

Description of the financial instrument, type of instrument

Arix Bioscience plc Ordinary shares of 0.001 pence each

Identification code

GB00BD045071

b)

Β 

Nature of the transaction

Β 

Share purchase

c)

Price(s) and volume(s)

Β 

Price(s)Β£

Volume(s)

Β 

Β 

Β 

1.1469

60,000

Β 

Β 

d)

Β 

Aggregated information

Β 

- Aggregated volume

60,000

- Price

Β£68,815.20

e)

Β 

Date of the transaction

Β 

2 November 2023

f)

Β 

Place of the transaction

Β 

Outside a trading venue

For further information please contact: Kin Company Secretarial Limited, Company Secretary+44 20 8819 6486


Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
ISIN:GB00BD045071
Category Code:DSH
TIDM:ARIX
LEI Code:213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:282417
EQS News ID:1764141
Β 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
10th Mar 20177:00 amRNSHolding(s) in Company
8th Mar 20177:00 amRNSHolding(s) in Company
6th Mar 20177:00 amRNSHoldings in Company
6th Mar 20177:00 amRNSHoldings in Company
2nd Mar 20177:00 amRNSArix signs strategic agreement with Takeda
28th Feb 20174:30 pmRNSMid-Stabilisation Period Announcement
22nd Feb 20178:08 amRNSArix Bioscience - admission to trading
17th Feb 20177:01 amRNSStabilisation Notice
17th Feb 20177:00 amRNSArix Bioscience raises £100m in IPO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.